Traditional Chinese medicine, Danlou tablets alleviate adverse left ventricular remodeling after myocardial infarction: results of a double-blind, randomized, placebo-controlled, pilot study

BACKGROUND: Danlou tablets, a patented Chinese Medicine, have been long approved for the treatment of ischemic heart disease in China. While numerous empirical observations suggested Danlou tablets could decrease frequency and duration of angina pectoris attacks, evidence supporting its efficacy on...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Shuai, Wang, Lei, Ouyang, Wenwei, Zhou, Yuanshen, Qi, Jianyong, Guo, Liheng, Zhang, Minzhou, Hinek, Aleksander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101662/
https://www.ncbi.nlm.nih.gov/pubmed/27825334
http://dx.doi.org/10.1186/s12906-016-1406-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101662/
https://www.ncbi.nlm.nih.gov/pubmed/27825334
http://dx.doi.org/10.1186/s12906-016-1406-4

Ejemplares similares